US patients "beware of Rx switching"

23 February 2009

Given the state of the US economy, when it comes to health care, there is a push by insurers to switch prescriptions written by physicians to  less expensive substitutes. But what looks like a favor to consumers  may be anything but, according to Ivan Abdouch, president of the  Nebraska Academy of Family Physicians. This can have unwanted effects  for patients, prolonging illnesses, increasing hospitalizations and  prompting other health issues. Consumers have the power to get the  medicine they need - and that their physicians prescribed - by asking  pharmacists four important questions prepared by Mark Alberts of  Northwestern University.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight